<DOC>
	<DOCNO>NCT00964964</DOCNO>
	<brief_summary>This trial conduct Europe . The aim compare change blood sugar number period carbohydrate supplementation need treat low blood sugar , two different treatment NN1250 ( insulin degludec ) , soluble insulin basal analogue ( SIBA ) subject type 1 diabetes .</brief_summary>
	<brief_title>A Trial Assessing Changes Blood Sugar Number Periods Where Supplementation Carbohydrate Needed Treat Low Blood Sugar , During Two Different Treatment Regimens NN1250 Type 1 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 1 diabetes mellitus least 12 month Glycosylated haemoglobin ( HbA1c ) 7.5 9 % ( inclusive ) Donation loss 500 ml blood plasma within three month prior trial Smoker ( define subject smoke 5 cigarette equivalent per day ) able willing refrain smoking use nicotine gum transdermal nicotine patch inhouse period Prior current treatment metformin thiazolidinediones</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>